Fludarabine-based Non-myeloablative Stem Cell Transplantation for Sickle Cell Disease with and without Renal Failure: Clinical Outcome and Pharmacokinetics

End-organ damage is common in patients with sickle cell disease (SCD) thereby limiting the use of allogeneic stem cell transplantation (SCT). We report the outcome of two adult SCD patients, one with end stage renal disease (ESRD), who underwent fludarabine-based non-myeloablative SCT from HLA-ident...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Horwitz, Mitchell E., Spasojevic, Ivan, Morris, Ashley, Telen, Marilyn, Essell, James, Gasparetto, Cristina, Sullivan, Keith, Long, Gwynn, Chute, John, Chao, Nelson, Rizzieri, David
פורמט: Artigo
שפה:Inglês
יצא לאור: 2007
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2153438/
https://ncbi.nlm.nih.gov/pubmed/18022571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2007.08.050
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים